ASX - By Stock
|
IHL |
Re:
General discussion
|
|
rhino78
|
19K |
6.6M |
13 |
01/04/23 |
01/04/23 |
ASX - By Stock
|
19K
|
6.6M
|
13
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
rhino78
|
19K |
6.6M |
22 |
25/03/23 |
25/03/23 |
ASX - By Stock
|
19K
|
6.6M
|
22
|
|
ASX - By Stock
|
IHL |
Re:
Industry news
|
|
rhino78
|
898 |
360K |
6 |
23/03/23 |
23/03/23 |
ASX - By Stock
|
898
|
360K
|
6
|
|
ASX - By Stock
|
IHL |
Re:
Industry news
|
|
rhino78
|
898 |
360K |
25 |
22/03/23 |
22/03/23 |
ASX - By Stock
|
898
|
360K
|
25
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Incannex Launches Psychedelic Clinics Business
|
|
rhino78
|
216 |
84K |
34 |
21/03/23 |
21/03/23 |
ASX - By Stock
|
216
|
84K
|
34
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
rhino78
|
19K |
6.6M |
45 |
17/03/23 |
17/03/23 |
ASX - By Stock
|
19K
|
6.6M
|
45
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Incannex Launches Psychedelic Clinics Business
|
|
rhino78
|
216 |
84K |
26 |
16/03/23 |
16/03/23 |
ASX - By Stock
|
216
|
84K
|
26
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Trading Halt
|
|
rhino78
|
69 |
33K |
12 |
11/03/23 |
11/03/23 |
ASX - By Stock
|
69
|
33K
|
12
|
|
ASX - Short Term Trading
|
|
Re:
Short Term Trading Week Starting: 03 Mar
|
|
rhino78
|
33 |
25K |
1 |
10/03/23 |
10/03/23 |
ASX - Short Term Trading
|
33
|
25K
|
1
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
rhino78
|
19K |
6.6M |
7 |
10/03/23 |
10/03/23 |
ASX - By Stock
|
19K
|
6.6M
|
7
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
rhino78
|
19K |
6.6M |
40 |
04/03/23 |
04/03/23 |
ASX - By Stock
|
19K
|
6.6M
|
40
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Incannex to Manufacture Psilocybin for Trials & Commercial
|
|
rhino78
|
65 |
29K |
21 |
03/03/23 |
03/03/23 |
ASX - By Stock
|
65
|
29K
|
21
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Incannex to Manufacture Psilocybin for Trials & Commercial
|
|
rhino78
|
65 |
29K |
38 |
03/03/23 |
03/03/23 |
ASX - By Stock
|
65
|
29K
|
38
|
|
ASX - By Stock
|
IHL |
Re:
Industry news
|
|
rhino78
|
898 |
360K |
8 |
02/03/23 |
02/03/23 |
ASX - By Stock
|
898
|
360K
|
8
|
|
ASX - By Stock
|
IHL |
Re:
general discussion
|
|
rhino78
|
129 |
41K |
24 |
15/02/23 |
15/02/23 |
ASX - By Stock
|
129
|
41K
|
24
|
|
ASX - By Stock
|
IHL |
Re:
general discussion
|
|
rhino78
|
129 |
41K |
14 |
13/02/23 |
13/02/23 |
ASX - By Stock
|
129
|
41K
|
14
|
|
ASX - By Stock
|
IHL |
Re:
general discussion
|
|
rhino78
|
129 |
41K |
13 |
10/02/23 |
10/02/23 |
ASX - By Stock
|
129
|
41K
|
13
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
rhino78
|
19K |
6.6M |
11 |
03/02/23 |
03/02/23 |
ASX - By Stock
|
19K
|
6.6M
|
11
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
rhino78
|
19K |
6.6M |
6 |
01/02/23 |
01/02/23 |
ASX - By Stock
|
19K
|
6.6M
|
6
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
rhino78
|
19K |
6.6M |
27 |
01/02/23 |
01/02/23 |
ASX - By Stock
|
19K
|
6.6M
|
27
|
|
ASX - By Stock
|
IHL Biotech |
Re:
IHL - INCANNEX - HOLDERS RESEARCH
|
|
rhino78
|
1.2K |
536K |
15 |
21/01/23 |
21/01/23 |
ASX - By Stock
|
1.2K
|
536K
|
15
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Independent data review commences for Ph 2 trial psilocybin
|
|
rhino78
|
46 |
18K |
26 |
18/01/23 |
18/01/23 |
ASX - By Stock
|
46
|
18K
|
26
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
rhino78
|
19K |
6.6M |
7 |
21/12/22 |
21/12/22 |
ASX - By Stock
|
19K
|
6.6M
|
7
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
rhino78
|
19K |
6.6M |
25 |
10/12/22 |
10/12/22 |
ASX - By Stock
|
19K
|
6.6M
|
25
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
rhino78
|
19K |
6.6M |
12 |
08/12/22 |
08/12/22 |
ASX - By Stock
|
19K
|
6.6M
|
12
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
rhino78
|
19K |
6.6M |
36 |
08/12/22 |
08/12/22 |
ASX - By Stock
|
19K
|
6.6M
|
36
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Incannex Undertakes A$13 Million Institutional Placement
|
|
rhino78
|
240 |
74K |
3 |
05/12/22 |
05/12/22 |
ASX - By Stock
|
240
|
74K
|
3
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Incannex Undertakes A$13 Million Institutional Placement
|
|
rhino78
|
240 |
74K |
8 |
05/12/22 |
05/12/22 |
ASX - By Stock
|
240
|
74K
|
8
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Incannex Undertakes A$13 Million Institutional Placement
|
|
rhino78
|
240 |
74K |
9 |
05/12/22 |
05/12/22 |
ASX - By Stock
|
240
|
74K
|
9
|
|
ASX - By Stock
|
IHL |
Re:
Ann: IHL commences manufacturing of skin therapeutics
|
|
rhino78
|
107 |
28K |
17 |
30/11/22 |
30/11/22 |
ASX - By Stock
|
107
|
28K
|
17
|
|
ASX - By Stock
|
IHL |
Re:
Ann: IHL commences manufacturing of skin therapeutics
|
|
rhino78
|
107 |
28K |
9 |
29/11/22 |
29/11/22 |
ASX - By Stock
|
107
|
28K
|
9
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
rhino78
|
51 |
17K |
19 |
24/11/22 |
24/11/22 |
ASX - By Stock
|
51
|
17K
|
19
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
rhino78
|
19K |
6.6M |
17 |
20/11/22 |
20/11/22 |
ASX - By Stock
|
19K
|
6.6M
|
17
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
rhino78
|
19K |
6.6M |
14 |
19/11/22 |
19/11/22 |
ASX - By Stock
|
19K
|
6.6M
|
14
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Incannex Development Update for IHL-42X
|
|
rhino78
|
32 |
14K |
7 |
17/11/22 |
17/11/22 |
ASX - By Stock
|
32
|
14K
|
7
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
rhino78
|
19K |
6.6M |
8 |
09/11/22 |
09/11/22 |
ASX - By Stock
|
19K
|
6.6M
|
8
|
|
ASX - By Stock
|
IHL |
Re:
CHART Thread
|
|
rhino78
|
3.0K |
1.1M |
18 |
27/10/22 |
27/10/22 |
ASX - By Stock
|
3.0K
|
1.1M
|
18
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
rhino78
|
19K |
6.6M |
5 |
14/09/22 |
14/09/22 |
ASX - By Stock
|
19K
|
6.6M
|
5
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
rhino78
|
19K |
6.6M |
13 |
14/09/22 |
14/09/22 |
ASX - By Stock
|
19K
|
6.6M
|
13
|
|
ASX - By Stock
|
IHL |
Re:
CHART Thread
|
|
rhino78
|
3.0K |
1.1M |
39 |
25/08/22 |
25/08/22 |
ASX - By Stock
|
3.0K
|
1.1M
|
39
|
|
ASX - By Stock
|
IHL |
Re:
CHART Thread
|
|
rhino78
|
3.0K |
1.1M |
15 |
29/07/22 |
29/07/22 |
ASX - By Stock
|
3.0K
|
1.1M
|
15
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
rhino78
|
19K |
6.6M |
9 |
13/07/22 |
13/07/22 |
ASX - By Stock
|
19K
|
6.6M
|
9
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
rhino78
|
19K |
6.6M |
17 |
13/07/22 |
13/07/22 |
ASX - By Stock
|
19K
|
6.6M
|
17
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Director and management update
|
|
rhino78
|
179 |
63K |
6 |
29/06/22 |
29/06/22 |
ASX - By Stock
|
179
|
63K
|
6
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Director and management update
|
|
rhino78
|
179 |
63K |
13 |
29/06/22 |
29/06/22 |
ASX - By Stock
|
179
|
63K
|
13
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Director and management update
|
|
rhino78
|
179 |
63K |
14 |
29/06/22 |
29/06/22 |
ASX - By Stock
|
179
|
63K
|
14
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
rhino78
|
19K |
6.6M |
16 |
22/06/22 |
22/06/22 |
ASX - By Stock
|
19K
|
6.6M
|
16
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
rhino78
|
19K |
6.6M |
26 |
10/06/22 |
10/06/22 |
ASX - By Stock
|
19K
|
6.6M
|
26
|
|
ASX - By Stock
|
IHL |
Re:
Ann: IHL-42X phase 2 clinical trial presentation
|
|
rhino78
|
111 |
40K |
15 |
04/06/22 |
04/06/22 |
ASX - By Stock
|
111
|
40K
|
15
|
|
ASX - By Stock
|
IHL Biotech |
Re:
IHL - INCANNEX - HOLDERS RESEARCH
|
|
rhino78
|
1.2K |
536K |
4 |
21/05/22 |
21/05/22 |
ASX - By Stock
|
1.2K
|
536K
|
4
|
|